Recent News

• 09.15.2025 - Stifel 2025 Virtual Immunology and Inflammation Forum
• 09.15.2025 - Stifel 2025 Virtual Immunology and Inflammation Forum
• 09.10.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.10.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.09.2025 - Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025
• 09.09.2025 - Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025
• 09.03.2025 - Nektar Therapeutics to Participate in Two Investor Conferences in September
• 09.03.2025 - Nektar Therapeutics to Participate in Two Investor Conferences in September

Recent Filings

• 09.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.05.2025 - 144 Report of proposed sale of securities
• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.04.2025 - 144 Report of proposed sale of securities
• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.04.2025 - 144 Report of proposed sale of securities
• 09.02.2025 - 144 Report of proposed sale of securities
• 09.02.2025 - 144 Report of proposed sale of securities
• 08.21.2025 - 4 Statement of changes in beneficial ownership of securities